Johnson & Johnson | The Robert Scott Bell Show

Government and Media Health Concerns Rappoport Reports

“Here we go again: FDA Commissioner in pocket of Big Pharma” By Jon Rappoport

April 17, 2017April 17, 2017 Robert Scott Bell and Glytec, AstraZeneca, Dr. Barbara Starfield, FDA commissioner, Gambro, Gilead, Gradalis, GSK, Johnson & Johnson, Jon Rappoport, Lilly, Martha Rosenberg, MedAvante, Merck, Public Citizen, Regeneron, Roche, Schering Plough, Scott Gottlieb

April 17, 2017 NoMoreFakeNews.com The excellent medical reporter, Martha Rosenberg, has written a piece at Salon: “The FDA Now Officially

Read more

RSB EXCLUSIVE: Bill Gates Urges Population Control Through Cell Phones, Fingerprinting and Vaccines?

November 21, 2010November 21, 2010 Robert Scott Bell adhd, aids, autism, Bill Gates, cell phone, clean water, Department of Health and Human Services, Education, fingerprints, Health care, HHS, immune disorders, Johnson & Johnson, location, Microsoft, National Institute of Health, nutrition, parents, Pfizer, population control, seizures, text4baby, vaccination rates, vaccines, Well Point

November 21st, 2010 By: Missy Fluegge If you could save the world one child at a time, how would you

Read more

Health Concerns

FDA: Popular Mouthwashes Make False Claims

September 29, 2010 RSB Staff claims, CVS, fda, gum, gum disease, gum health, Johnson & Johnson, mouthwash, plaque, sodium fluoride, unproven, Walgreen

The FDA has warned Walgreen Co., Johnson & Johnson, and CVS Corp. to stop making unproven claims that their mouth

Read more

Health Concerns

Tylenol Side Effects Unveiled

September 20, 2010 RSB Staff Benadryl, deaths, drugs, fda, investigation, Johnson & Johnson, McNeil, Motrin, pain, products, recall, side effects, The House Committee on Oversight and Government Reform, tylenol

The FDA has announced that it is investigating reports of at least 775 serious side effects, including 30 deaths, associated

Read more

Health Concerns

Johnson & Johnson to Buy Vaccine Group

September 17, 2010 RSB Staff Crucell, Dutch, Johnson & Johnson, Leiden, Netherlands, US cosmetics, Vaccine Group

US cosmetics and pharmaceutical giant Johnson and Johnson said on Friday it intends to acquire Dutch vaccine maker Crucell, which

Read more

Government and Media

Johnson & Johnson Loses Over Criminal Promotion Of Topomax

July 28, 2010 RSB Staff anticonvulsant drug, criminal charges, Criminal Promotion, Doctor, False Clamis Act, Federal Government, fraud, illegally marketing, Johnson & Johnson, Medicaid, misbranding, topomax, Tylenol scandal, U.S. Justice Department

As if the children’s Tylenol scandal is not enough, Johnson & Johnson is now facing additional criminal charges over another

Read more

Government and Media Health Concerns

Medical Flops Of The Decade

June 28, 2010 RSB Staff Avandia, genome, GlaxoSmithkline's, Gleevec, Johnson & Johnson, leukemia, medical device companies, Motrin, pharmaceutical, tylenol, unprecedented cornucopia, Vioxx, Zocor

When it comes to product safety, it has been a rough decade for pharmaceutical and medical device companies. The drug

Read more

Health Concerns

FDA: no shortage of kids’ medicines seen

June 28, 2010 RSB Staff allergy medications, Benadryl, diversified healthcare company, Elaine Bobo, food and drug administration, Johnson & Johnson, Leerink Swann, McNeil Consumer Healthcare, Motrin, PediaCare, Pennsylvania, Perrigo, Rick Wise, tylenol, U.S. House of Representatives Oversight Committee Chairman Edolphus Towns, Washington, Zyrtec

U.S. health regulators said on Friday they do not expect any shortage of children’s pain and allergy medications despite Johnson

Read more

Health Concerns

FDA: no shortage of kids' medicines seen

June 28, 2010 Robert Scott Bell allergy medications, Benadryl, diversified healthcare company, Elaine Bobo, food and drug administration, Johnson & Johnson, Leerink Swann, McNeil Consumer Healthcare, Motrin, PediaCare, Pennsylvania, Perrigo, Rick Wise, tylenol, U.S. House of Representatives Oversight Committee Chairman Edolphus Towns, Washington, Zyrtec

U.S. health regulators said on Friday they do not expect any shortage of children’s pain and allergy medications despite Johnson

Read more